Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Quotient Limited (QTNT : NSDQ)
 
 • Company Description   
Quotient Limited is a commercial-stage transfusion diagnostics company. It is focused on supplying blood-grouping consumables and developing MosaiQ, a fully automated platform for use in donor centers and patient-testing sites. Quotient Limited is headquartered in Edinburgh, Scotland and Newton, Pennsylvania.

Number of Employees: 182

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.39 Daily Weekly Monthly
20 Day Moving Average: 631,579 shares
Shares Outstanding: 102.60 (millions)
Market Capitalization: $40.35 (millions)
Beta: 2.70
52 Week High: $4.53
52 Week Low: $0.38
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -44.06% -38.95%
12 Week -69.51% -67.90%
Year To Date -84.82% -82.30%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
B1 Business Park Terre Bonne Route de Crassier 13
-
Eysins,Y9 1262
CHE
ph: 011-41-22-716-9800
fax: -
ir@quotientbd.com http://www.quotientbd.com
 
 • General Corporate Information   
Officers
Manuel O. Mendez - Chief Executive Officer
Heino von Prondzynski - Chairman of the Board of Directors
Peter Buhler - Chief Financial Officer
Catherine Larue - Director
Frederick Hallsworth - Director

Peer Information
Quotient Limited (ABMD)
Quotient Limited (DMDS)
Quotient Limited (CPWY.)
Quotient Limited (EQUR)
Quotient Limited (ECIA)
Quotient Limited (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: G73268107
SIC: 2835
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 06/07/22
Share - Related Items
Shares Outstanding: 102.60
Most Recent Split Date: (:1)
Beta: 2.70
Market Capitalization: $40.35 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.31 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.02 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/07/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 1.05
EPS Growth
vs. Year Ago Period: -51.72%
vs. Previous Quarter: -57.14%
Sales Growth
vs. Year Ago Period: 16.24%
vs. Previous Quarter: 7.45%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -56.41
09/30/21 - -48.23
Current Ratio
03/31/22 - -
12/31/21 - 5.77
09/30/21 - 5.84
Quick Ratio
03/31/22 - -
12/31/21 - 4.83
09/30/21 - 5.03
Operating Margin
03/31/22 - -
12/31/21 - -350.92
09/30/21 - -323.64
Net Margin
03/31/22 - -
12/31/21 - -350.92
09/30/21 - -323.64
Pre-Tax Margin
03/31/22 - -
12/31/21 - -357.83
09/30/21 - -333.86
Book Value
03/31/22 - -
12/31/21 - -1.23
09/30/21 - -0.84
Inventory Turnover
03/31/22 - -
12/31/21 - 0.98
09/30/21 - 0.84
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©